Skip to main content

Table 1 Clinical score changes in G1 and G2 treated dogs during follow-up post-therapy. Data are reported as mean and (SD)

From: Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol

Time course G1 G2 p*
months n = 9 n = 9
Basal 6.2 6.0 0.3894
(1.6) (1.7)
1 1.7 3.7 0.0051
(1.7) (1.2)
3 1.3 1.7 0.1922
(1.0) (0.5)
6 0.6 2.3 0.0246
(0.7) (2.4)
9 0.0 1.0 0.0380
(0.0) (1.6)
12 0.9 0.4 0.3180
(2.7) (0.7)
15 0.2 0.1 0.3304
(0.7) (0.3)
18 0.1 0.3 0.1418
(0.3) (0.5)
21 0.1 0.3 0.1418
(0.3) (0.5)
24 0.2 0.3 0.3119
(0.4) (0.5)
28 0.3 0.9 0.0862
(0.7) (0.9)
36 0.0 0.4 0.0111
(0.0) (0.5)
48 0.0 0.8 0.0243
(0.0) (1.1)
60 0.0 0.4 0.0750
(0.0) (0.9)
72 0.0 0.4 0.0426
(0.0) (0.7)
  1. *Student’s t-test probability significance between groups